Involvement of NOX1/NADPH oxidase in morphine-induced analgesia and tolerance

Journal of Neuroscience

Volumn 31, Issue 49, 2011, Pages 18094-18103

  Ibi, Masakazu ^a   Matsuno, Kuniharu ^a   Matsumoto, Misaki ^a   Sasaki, Mika ^a   Nakagawa, Takayuki ^b   Katsuyama, Masato ^a   Iwata, Kazumi ^a   Zhang, Jia ^a   Kaneko, Shuji ^b   Yabe Nishimura, Chihiro ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ENKEPHALIN [2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; GUANOSINE TRIPHOSPHATASE; MORPHINE; OXIDOREDUCTASE; PROTEIN KINASE C; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; SULFUR 35; SUPEROXIDE; UNCLASSIFIED DRUG;

ANALGESIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG TOLERANCE; GENOTYPE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MALE; MOUSE; NOCICEPTION; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SPINAL CORD;

ANIMALS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG TOLERANCE; EMBRYO, MAMMALIAN; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; GANGLIA, SPINAL; GENE EXPRESSION REGULATION; GTP PHOSPHOHYDROLASES; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); GUANOSINE TRIPHOSPHATE; HYPERALGESIA; MALE; MICE; MICE, KNOCKOUT; MORPHINE; NADH, NADPH OXIDOREDUCTASES; NARCOTICS; NEUROGLIA; NEURONS; PAIN MEASUREMENT; PAIN THRESHOLD; PROTEIN KINASE C; RGS PROTEINS; RNA, MESSENGER; SPINAL CORD; SULFUR ISOTOPES; SUPEROXIDES; TRITIUM;

EID: 83055160848     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.4136-11.2011     Document Type: Article

References (45)

1. Abramow-Newerly M, Roy AA, Nunn C, Chidiac P (2006) RGS proteins havea signaling complex; interactions between RGS proteins and GPCRs, effectors, and auxiliary proteins. Cell Signal 18:579-591.
2. Arttamangkul S, Torrecilla M, Kobayashi K, Okano H, Williams JT (2006) Separation ofmu-opioid receptor desensitization and internalization: en-dogeneous receptors in primary neuronal cultures. J Neurosci 26:4118-4125.
3. Bailey CP, Smith FL, Kelly E, Dewey WL, Henderson G (2006) How important is protein kinase C in mu-opioid receptor desensitization and morphine tolerance? Trends Pharmacol Sci 27:558-565.
4. Bilsky EJ, Bernstein RN, Wang Z, Sadée W, Porreca F (1996) Effects of nal-oxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance. J Pharmacol Exp Ther 277:484-490.
5. Cui W, Matsuno K, Iwata K, Ibi M, Katsuyama M, Kakehi T, Sasaki M, Ikami K, Zhu K, Yabe-Nishimura C (2009) NADPH oxidase isoforms and anti-hypertensive effects of atrovastatin demonstrated in two animal models. J Pharmacol Sci 111:260-268.
6. Cui W, Matsuno K, Iwata K, Ibi M, Matsumoto M, Zhang J, Zhu K, Katsuy-ama M, Torok NJ, Yabe-Nishimura C (2011) NOX1/nicotinamide adenine dinucleotide phosphate, reduced from (NADPH) oxidase promotes proliferation of stellate cells and aggravates liver fiblosis induced by bile duct ligation. Hepatology 54:949-958.
7. Doyle T, Bryant L, Batinic-Haberle I, Little J, Cuzzocrea S, Masini E, Spaso-jevic I, Salvemini D (2009) Supraspinal inactivation of mitochondrial superoxide dismutase is a source of peroxynitrite in the development of morphine antinociceptive tolerance. Neuroscience 164:702-710.
8. Doyle T, Bryant L, Muscoli C, Cuzzocrea S, Esposito E, Chen Z, Salvemini D (2010) Spinal NADPH oxidase is a source of superoxide in the development of morphine-induced hyperalgesia and antinociceptive tolerance. Neurosci Lett 483:85-89.
9. Garzon J, Martínez-Peña Y, Sanchez-Blazquez P (1997) Gx/z is regulated by μbut not δ opioid receptors in stimulation of the low Km GTPase activity in mouse periaqueductal grey matter. Eur J Neurosci 9:1194-1200.
10. Garzon J, Rodríguez-Díaz M, Lopez-Fando A, Sanchez-Blazquez P (2001) RGS9 proteins facilitate acute tolerance to mu-opioid effects. Eur J Neurosci 13:801-811.
11. Garzon J, Rodríguez-Muñoz M, Lopez-Fando A, Sanchez-Blazquez P (2005) Activation of mu-opioid receptors transfers control of Galpha subunits to the regulator of G-protein signaling RGS9-2: role in receptor desensitiza-tion. J Biol Chem 280:8951-8960.
12. Garzon J, Rodríguez-Muñoz M, Sanchez-Blazquez P (2008) Do pharmacological approaches that prevent opioid tolerance target different elements in the same regulatory machinery? Curr Drug Abuse Rev 1:222-238.
13. Gold SJ, Ni YG, Dohlman HG, Nestler EJ (1997) Regulators of G-protein signaling (RGS) proteins: region-specific expression of nine subtypes in rat brain. J Neurosci 17:8024-8037.
14. Groer CE, Tidgewell K, Moyer RA, Harding WW, Rothman RB, Prisinzano TE, Bohn LM (2007) An opioid agonist that does not induced m-opioid receptor-arrestin interactions or receptor internalization. Mol Pharmacol 71:549-557.
15. Harraz MM, Marden JJ, Zhou W, Zhang Y, Williams A, Sharov VS, Nelson K, Luo M, Paulson H, Schoneich C, Engelhardt JF (2008) SOD1 mutations disrupt redox-sensitive Rac regulation of NADPH oxidase in a familial ALS model. J Clin Invest 118:659-670.
16. Heo J (2011) Redox control of GTPase: from molecular mechanisms to functional significance in health and disease. Antioxid Redox Signal 14:689-724.
17. Heumüller S, Wind S, Barbosa-Sicard E, Schmidt HH, Busse R, Schroder K, Brandes RP (2008) Apocynin is not an inhibitor of vascular NADPH oxidase but an antioxidant. Hypertension 51:211-217.
18. Hollinger S, Hepler JR (2002) Cellular regulation of RGS proteins: modulators and integrators of G protein signaling. Pharmacol Rev 54:527-559.
19. Ibi M, Matsuno K, Shiba D, Katsuyama M, Iwata K, Kakehi T, Nakagawa T, Sango K, Shirai Y, Yokoyama T, Kaneko S, Saito N, Yabe-Nishimura C (2008) Reactive oxygen species derived from NOX1/NADPH oxidase enhance inflammatory pain. J Neurosci 28:9486-9494.
20. Johnson EA, Oldfield S, Braksator E, Gonzalez-Cuello A, Couch D, Hall KJ, Mundell SJ, Bailey CP, Kelly E, Henderson G (2006) Agonist-selective mechanisms of mu-opioid receptor desensitization in human embryonic kidney 293 cells. Mol Pharmacol 70:676-685.
21. Kilpatrick GJ, Smith TW (2005) Morphine-6-glucuronide: actions and mechanisms. Med Res Rev 25:521-544.
22. Kim D, You B, Jo EK, Han SK, Simon MI, Lee SJ (2010) NADPH oxidase 2-derived reactive oxygen species in spinal cord microglia contribute to peripheral nerve injury-induced neuropathic pain. Proc Natl Acad Sci USA 107:14851-14856.
23. Lan KL, Zhong H, Nanamori M, Neubig RR (2000) Rapid kinetics of regulator of G-protein signaling (RGS)-mediated Galphai and Gal-phao deactivation. Galpha specificity of RGS4 AND RGS7. J Biol Chem 275:33497-33503.
24. Matsuno K, Yamada H, Iwata K, Jin D, Katsuyama M, Matsuki M, Takai S, Yamanishi K, Miyazaki M, Matsubara H, Yabe-Nishimura C (2005) Nox1 is involved in angiotensin II-mediated hypertension: a study in Nox1-deficient mice. Circulation 112:2677-2685.
25. Minami M, Onogi T, Nakagawa T, Katao Y, Aoki Y, Katsumata S, Satoh M (1995) DAMGO, a μ-opioid receptor selective ligand, distinguishes between μ- and K{green}-opioid receptors at a different regions from that for the distinction between μ- and δ-opioid receptors. FEBS Lett 364:23-27.
26. Muscoli C, Cuzzocrea S, Ndengele MM, Mollace V, Porreca F, Fabrizi F, Esposito E, Masini E, Matuschak GM, Salvemini D (2007) Therapeutic manipulation of peroxynitrite attenuates the development of opiate-induced antinociceptive tolerance in mice. J Clin Invest 117:3530-3539.
27. Nakagawa T, Ozawa T, Watanabe T, Minami M, Satoh M (1999) Sensitization of the adenylyl cyclase system in cloned kappa-opioid receptor-transfected cells following sustained agonist treatment: A chimeric study using G protein αi2/αq subunits. Jpn J Pharmacol 81:353-361.
28. Narita M, Mizoguchi H, Narita M, Nagase H, Suzuki T, Tseng LF (2001) Involvement of spinal protein kinase Cgamma in the attenuation of opioid mu-receptor-mediated G-protein activation after chronic intrathecal administration of [D-Ala2,N-MePhe4,Gly-Ol(5)]enkephalin. J Neurosci 21:3715-3720.
29. Polgar E, Fowler JH, McGill MM, Todd AJ (1999) The types of neuron which contain protein kinase C gamma in rat spinal cord. Brain Res 833:71-80.
30. Rahman Z, Gold SJ, Potenza MN, Cowan CW, Ni YG, He W, Wensel TG, Nestler EJ (1999) Cloning and chanracterization of RGS9-2: a striatal enriched alternative spliced product of the RGS9 gene. J Neurosci 19:2016-2026.
31. Rodríguez-Muñoz M, de la Torre-Madrid E, Sanchez-Blazquez P, Garzon J (2007) Morphine induces endocytosis of neuronal mu-opioid receptors through the sustained transfer of Galpha subunits to RGSZ2 proteins. Mol Pain 3:19.
32. Rodríguez-Muñoz M, de la Torre-Madrid E, Sanchez-Blazquez P, Wang JB, Garzon J (2008) NMDAR-nNOS generated zinc recruits PKCgamma to the HINT1-RGS17 complex bound to the C terminus of Mu-opioid receptors. Cell Signal 20:1855-1864.
33. Rodríguez-Muñoz M, de la Torre-Madrid E, Sanchez-Blazquez P, Garzon J (2011) NO-released zinc supports the simultaneous binding of Raf-1 and PKCγ cysteine-rich domains to HINT1 protein at the mu-opioid receptor. Antioxid Redox Signal 14:2413-2425.
34. Rokyta R, Holecek V, Pekarkova I, Krejcova J, Racek J, Trefil L, Yamamotova A (2003) Free radicals after pain stimulation are influenced by antioxidants and analgesics. Neuro Endocrinol Lett 24:304-309.
35. Schwartz ES, Lee I, Chung K, Chung JM (2008) Oxidative stress inthe spinal cord is an important contributor in capsaicin-induced mechanical secondary hyperalgesia in mice. Pain 138:514-524.
36. Shinohara M, Shang WH, Kubodera M, Harada S, Mitsushita J, Kato M, Miyazaki H, Sumimoto H, Kamata T (2007) Nox1 redox signaling mediates oncogenic Ras-induced disruption of stress fibers and focal adhesions by down-regulating Rho. J Biol Chem 282:17640-17648.
37. Smith FL, Gabra BH, Smith PA, Redwood MC, Dewey WL (2007) Determination of the role of conventional, novel and atypical PKC isoforms in the expression of morphine tolerance in mice. Pain 127:129-139.
38. Sorce S, Krause KH (2009) NOX enzymes in the central nervous system: from signaling to disease. Antioxid Redox Signal 11:2481-2504.
39. Urushitani M, Sik A, Sakurai T, Nukina N, Takahashi R, Julien JP (2006) Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis. Nat Neurosci 9:108-118.
40. van Dorp EL, Romberg R, Sarton E, Bovill JG, Dahan A (2006) Morphine-6-glucuronide: morphine's successor for postoperative pain relief? Anesthesia and analgesia 102:1789-1797.
41. Willars GB (2006) Mammalian RGS proteins: Multifunctional regulators of cellular signaling. Semin Cell Dev Biol 17:363-376.
42. Winsky-Sommerer R, Yamanaka A, Diano S, Borok E, Roberts AJ, Sakurai T, Kilduff TS, Horvath TL, de Lecea L (2004) Interaction between the corticotropin-releasing factor system and hypocretins (orexins): a novel circuit mediating stress response. J Neurosci 24:11439-11448.
43. Zachariou V, Georgescu D, Sanchez N, Rahman Z, DiLeone R, Berton O, Neve RL, Sim-Selley LJ, Selley DE, Gold SJ, Nestler EJ (2003) Essential role for RGS9 in opiate action. Proc Natl Acad Sci U S A 100:13656-13661.
44. Zhang J, Ferguson SS, Barak LS, Bodduluri SR, Laporte SA, Law PY, Caron MG (1998) Role for G protein-coupled receptor kinase in agonist-specific regulation of mu-opioid receptor responsiveness. Proc Natl Acad Sci U S A 95:7157-7162.
45. Zmijewski JW, Song L, Harkins L, Cobbs CS, Jope RS (2001) Oxidative stress and heat shock stimulate RGS2 expression in 1321N1 astrocytoma cells. Arch Biochem Biophys 392:192-196.